Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Go back to Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
(NASDAQ: DNLI) Delayed: 23.80 +0.49 (2.10%)
Previous Close $23.31    52 Week High
Open $23.90    52 Week Low
Day High $24.34    P/E N/A 
Day Low $23.66    EPS
Volume 404,762